Does AFINITOR UNKNOWN Cause Malignant neoplasm progression? 7 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Malignant neoplasm progression have been filed in association with AFINITOR UNKNOWN. This represents 20.0% of all adverse event reports for AFINITOR UNKNOWN.
7
Reports of Malignant neoplasm progression with AFINITOR UNKNOWN
20.0%
of all AFINITOR UNKNOWN reports
1
Deaths
3
Hospitalizations
How Dangerous Is Malignant neoplasm progression From AFINITOR UNKNOWN?
Of the 7 reports, 1 (14.3%) resulted in death, 3 (42.9%) required hospitalization.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for AFINITOR UNKNOWN. However, 7 reports have been filed with the FAERS database.
What Other Side Effects Does AFINITOR UNKNOWN Cause?
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)